PURCHASE OPTION AGREEMENT by and among GUILFORD PHARMACEUTICALS INC., SNDC HOLDINGS LLC and SYMPHONY NEURO DEVELOPMENT COMPANYPurchase Option Agreement • June 21st, 2004 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This PURCHASE OPTION AGREEMENT (this “Agreement”) is entered into as of June 17, 2004 by and among Guilford Pharmaceuticals Inc., a Delaware corporation (“Guilford”), SNDC Holdings LLC, a Delaware limited liability company (“Holdings”), and Symphony Neuro Development Company, a Delaware corporation (“SNDC”). Capitalized terms used herein and not defined herein shall have the meanings assigned to such terms in Annex A attached hereto.
NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT dated as of June 17, 2004 between GPI NIL HOLDINGS, INC., GUILFORD PHARMACEUTICALS INC., SYMPHONY NEURO DEVELOPMENT COMPANY and SNDC HOLDINGS LLCNovated and Restated Technology License Agreement • June 21st, 2004 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations • New York
This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and effective as of June 17, 2004 (the “Effective Date”) by and between GPI NIL Holdings, Inc., a Delaware corporation (“GPI”), Guilford Pharmaceuticals Inc., a Delaware corporation (“Guilford,” and together with GPI, “Licensor”), Symphony Neuro Development Company, a Delaware corporation (“SNDC”) (each of Licensor and SNDC being a “Party,” and collectively, the "Parties”), and SNDC Holdings LLC, a Delaware limited liability company (“Holdings”).
